7Baggers

Cyclo Therapeutics Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Current Account Receivables  
 Current Account Payables  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 00.941.892.833.774.725.666.6Milllion

Cyclo Therapeutics Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
  current account reveivables122,379 303,760 88,391 131,224 54,991 394,570 438,694 157,715 539,090 399,934 224,484 220,168 111,789 124,565 200,294 207,884 182,490 73,181 191,549 112,235 
  current account payables4,856,530 6,604,504 6,078,097 4,482,600 3,480,669 2,870,085 2,091,968 2,861,582 2,930,267 4,458,191 2,622,511 

We provide you with 20 years of balance sheets for Cyclo Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cyclo Therapeutics. Explore the full financial landscape of Cyclo Therapeutics stock with our expertly curated balance sheets.

The information provided in this report about Cyclo Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.